World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
23397
World Ranking
15212
National Ranking
579

Overview

Philip M. Kluin is affiliated with the University Medical Center Groningen in the Netherlands. Their research spans multiple fields within medicine and biomedical sciences, with a particular focus on hematology, oncology, genetics, and immunology.

The scientist's work prominently covers several key topics:

  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Mast cells and histamine
  • Melanin and skin pigmentation
  • Chronic Lymphocytic Leukemia Research
  • Cancer Immunotherapy and Biomarkers

Philip M. Kluin has contributed to research published in a variety of academic journals. Frequent publication venues include:

  • Blood
  • Blood Advances
  • The Journal of Allergy and Clinical Immunology In Practice
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • International Journal of Laboratory Hematology

Several of their recent papers illustrate the scope of their research. These include:

  • Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations (2021, Blood)
  • Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21) (2021, Blood Advances)
  • Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group (2022, The Journal of Allergy and Clinical Immunology In Practice)
  • Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features (2021, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin)
  • Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure (2020, International Journal of Laboratory Hematology)

Frequent co-authors collaborating with Philip M. Kluin include:

  • Peter Valent
  • Thomas Kielsgaard Kristensen
  • Tracy I. George
  • Wolfgang R. Sperr
  • Cem Akin

Their body of work reflects substantial engagement with both clinical and molecular aspects of hematologic malignancies and immune-related disorders. This includes investigation into diagnostic standards, molecular alterations, and treatment challenges associated with various blood cancers and systemic pathologies.

Philip M. Kluin's research contributes to advancing understanding in diverse but interconnected topics within medicine, including the genetics of blood disorders, pathology, and immune biomarkers relevant to cancer therapy and disease prognosis.

Best Publications

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar

  • Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

    S. A. Pileri;T. M. Grogan;N. L. Harris;P Banks

  • Double-hit B-cell lymphomas

    Sietse M. Aukema;Reiner Siebert;Ed Schuuring;Gustaaf W. van Imhoff

  • Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity

    P. P. Tak;T. J. M. Smeets;M. R. Daha;P. M. Kluin

  • Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma

    M.H.H. Kramer;J. Hermans;E. Wijburg;K. Philippo

  • Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.

    P P Tak;P C Taylor;F C Breedveld;T J Smeets

  • Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.

    Markus Tiemann;Carsten Schrader;Wolfram Klapper;Martin H. Dreyling

  • Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO–EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers

    Nancy J. Senff;Juliette J. Hoefnagel;Patty M. Jansen;Maarten H. Vermeer

  • Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets: Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

    P. A. S. Evans;Ch Pott;P. J. T. A. Groenen;G. Salles

  • Involvement of the CCND1 gene in hairy cell leukemia

    C J de Boer;Johanna Kluin-Nelemans;E Dreef;M G Kester

  • Response to interferon alfa-2b in a patient with systemic mastocytosis.

    Hanneke C. Kluin-Nelemans;Joop H. Jansen;Henk Breukelman;Bert G Wolthers

  • Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

    Annuska M. Glas;Laurent Knoops;Leonie Delahaye;Marie Jose Kersten

  • Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

    Annuska M Glas;Marie José Kersten;Leonie J M J Delahaye;Anke T Witteveen

  • Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.

    Sietske A. Riemersma;Ekaterina S. Jordanova;Roelandt F. J. Schop;Katja Philippo

  • Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients.

    Marcel W Bekkenk;Maarten H Vermeer;Patty M Jansen;Ariënne M W van Marion

  • Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis

    P. P. Tak;P. A. Van Der Lubbe;A. Cauli;M. R. Daha

  • Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge

    E G Boerma;R Siebert;P M Kluin;Michael Baudis

  • Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome

    J. Pijpe;Warner Kalk;J. E. van der Wal;Arjan Vissink

  • Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma

    C. J. De Boer;E. Schuuring;E. Dreef;G. Peters

Frequent Co-Authors

Ed Schuuring
Ed Schuuring University Medical Center Groningen
Anke van den Berg
Anke van den Berg University Medical Center Groningen
Hanneke C. Kluin-Nelemans
Hanneke C. Kluin-Nelemans University Medical Center Groningen
Reiner Siebert
Reiner Siebert University of Ulm
Steven T. Pals
Steven T. Pals University of Amsterdam
Klaas Kok
Klaas Kok University of Groningen
Sibrand Poppema
Sibrand Poppema Sunway University
Edo Vellenga
Edo Vellenga University Medical Center Groningen
Ekaterina S. Jordanova
Ekaterina S. Jordanova Vrije Universiteit Amsterdam
Miguel-Angel Perales
Miguel-Angel Perales Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or complementary career pathways in healthcare can broaden your horizons while studying Medicine in the USA. The growing demand for nurses and healthcare leaders makes online degrees an appealing option for many students.

Many consider advancing their education with specialized programs, such as phd nursing programs, which offer flexibility and open doors to research or academic careers. For registered nurses looking to boost their credentials, enrolling in one of the cheapest accredited online rn to bsn programs is a cost-effective way to expand job opportunities and increase earning potential.

Non-nurses interested in entering the profession may find entry level msn programs online a fast-track to advanced nursing roles—all without a prior nursing background. If you're concerned about admissions competitiveness, research whats the easiest nursing program to get into? for flexible pathway options that fit your academic profile.

Pursuing these online degrees not only enhances your medical knowledge, but also provides diverse career paths in today's dynamic healthcare landscape.

Best Scientists Citing Philip M. Kluin

Trending Scientists

Recently Published Articles